Home » Archive

Xconomy

News, Syndication, Xconomy »

Illumina, Yuri Milner Open Genomics Startup Accelerator in SF

Posted by sandiegobiotech February 12th, 2014 .
No Comments

Entrepreneurs who want to use high-powered DNA sequencers for, say, a new way to diagnose cancer, are in much the same boat as infotech entrepreneurs a decade ago. Before they can even develop a…

[[Click headline to continue reading.]]

More...

News, Syndication, Xconomy »

The Young and Proven Biotech VCs From 2012. Where Are They Now?

Posted by sandiegobiotech February 10th, 2014 .
No Comments

One of the old saws in journalism is to “follow the money” when you’re looking for a story. But sometimes you learn even more by following the people. The people, in this case, are biotech venture…

[[Click headline to continue reading.]]

More...

News, Syndication, Xconomy »

San Diego Life Sciences Roundup: Accelrys, Celladon’s IPO, and More

Posted by sandiegobiotech January 31st, 2014 .
No Comments

A buyout offer for Accelrys, a new stem cell center of excellence, and an IPO. Not bad for one week of life sciences news. But wait, there’s more… —French software developer Dassault Systèmes…

[[Click headline to continue reading.]]

More...

News, Syndication, Xconomy »

$40M Establishes New Center for Stem Cell Genomics in Bay Area, SD

Posted by sandiegobiotech January 29th, 2014 .
No Comments

The California Institute for Regenerative Medicine today awarded $40 million to create a new Center of Excellence in Stem Cell Genomics, to be led by Stanford University molecular geneticist Michael…

[[Click headline to continue reading.]]

More...

Diagnostics, News, Syndication, Xconomy »

Epic Sciences Compiling Data on Ultra-Sensitive Cancer Diagnostic

Posted by sandiegobiotech January 29th, 2014 .
No Comments

San Diego’s Epic Sciences said today it has signed an agreement with LabCorp (NYSE: LH) to help speed up European clinical trials that are using Epic’s technology to identify tumor cells in the…

[[Click headline to continue reading.]]

More...

Drug Discovery, News, Syndication, Xconomy »

With Record $275M Gift, Sanford-Burnham Unveils New 10-Year Plan

Posted by sandiegobiotech January 28th, 2014 .
No Comments

San Diego’s Sanford-Burnham Medical Research Institute says today it has landed a $275 million pledge from an anonymous donor, just as the institute is embarking on a new 10-year strategic plan. The…

[[Click headline to continue reading.]]

More...

Drug Development, News, Syndication, Xconomy »

What the World Needs Now Is (Probably Not) a Pill for Perfect Pitch

Posted by sandiegobiotech January 27th, 2014 .
No Comments

I remember seeing an episode of Desperate Housewives during the show’s first season called Running to Stand Still. In the episode, Lynette, working mom of many, takes her kid’s ADD medicine in order…

[[Click headline to continue reading.]]

More...

Diagnostics, News, Syndication, Xconomy »

Using Cutting-Edge Science and Technology Against an Age-Old Disease

Posted by sandiegobiotech January 24th, 2014 .
No Comments

When I started working on the research and science of leprosy more than a decade ago, people thought this chronic infectious disease would eliminate itself and burn out over time. We didn’t have time…

[[Click headline to continue reading.]]

More...

News, Syndication, Xconomy »

San Diego Life Sciences Roundup: Shire, Illumina, Tandem, and More

Posted by sandiegobiotech January 24th, 2014 .
No Comments

Much of the week’s life sciences news concerned the end-of-year data on venture capital activity, and how much money flowed into San Diego’s biotech and device companies in 2013. And then there…

[[Click headline to continue reading.]]

More...

News, Syndication, Xconomy »

With Biotech IPO Outlet, San Diego Venture Funding at 15-Year Low

Posted by sandiegobiotech January 21st, 2014 .
No Comments

Venture capital firms invested almost $758 million in 97 startups in the San Diego region last year, marking the slowest pace in 15 years, according to data from the MoneyTree Report. Compared with…

[[Click headline to continue reading.]]

More...